# ImmunityBio: Health Care, Culver City, United States

> ImmunityBio: ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Source: https://millionrounds.com/startup/immunitybio (Millionrounds; every figure on the page links to its filing or article)

United States · [Health Care startup](https://millionrounds.com/companies)

# ImmunityBio

ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Funding reported Last round: Post ipo debt

Health Care Culver City, United States

Company summary

- **Founded:** 2014 12 years old
- **Team:** 501 201 to 1,000 people
- **Funding reported:** $1.1B in dollars
- **Last round:** Post ipo debt Jan 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for ImmunityBio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say ImmunityBio raised

Funding, as reported

Reported in all **$1.1B** in dollars

Rounds **13**

Last round **Post ipo debt**

Last round date **Jan 2024**

Investors listed **3**

## Founders and team

From ImmunityBio's own website and the SEC filings it signed: 9 on the team.

- **Rich Adcock** President & Chief Executive Officer
- **Elizabeth Gabitzsch** Senior Vice President, Product Development & Vaccine Programs
- **Emily Arison** Senior Vice President of Human Resources
- **Matthew Hilman** Vice President US Commercial – Urologic Oncology
- **Sarah Singleton** Chief Communications Officer & Head of Patient Advocacy
- **Regan Lauer** Chief Accounting Officer
- **David Sachs** Chief Financial Officer
- **Dr. Patrick Soon-Shiong** Executive Chairman and Global Chief
- **Richard Adcock** Executive Officer, Director i

On the board, as filed i *Barry Simon* *Cheryl Cohen* *Christobel Selecky* *John Brennan* *Linda Maxwell* *Michael Blaszyk* *Wesley Clark*

## On 2 portfolio pages

Investors who name them

- [Sanderling Ventures](https://millionrounds.com/fund/sanderling-ventures)
- [Oberland Capital](https://millionrounds.com/fund/oberland-capital)

Each firm lists ImmunityBio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Health Care in United States

Startups like it

- [**Viking Therapeutics** San Diego · founded 2012](https://millionrounds.com/startup/viking-therapeutics)
- [**Verano Holdings** Chicago · founded 2017](https://millionrounds.com/startup/verano-holdings)
- [**Healogics** Jacksonville · founded 1996](https://millionrounds.com/startup/healogics)
- [**Caretrust** San Clemente · founded 2014](https://millionrounds.com/startup/caretrust)
- [**GI Alliance** Allen · founded 2018](https://millionrounds.com/startup/gi-alliance)
- [**Transcarent** San Francisco · founded 2020](https://millionrounds.com/startup/transcarent)
- [**Cerebral** San Francisco · founded 2020](https://millionrounds.com/startup/cerebral)
- [**MJH Life Sciences** Cranbury · founded 2018](https://millionrounds.com/startup/mjh-life-sciences)

## Is this your company?

Add your raise, your deck and your story, and put ImmunityBio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)